Abstract
Methicillin-resistant strains of Staphylococcus aureus (MRSA) are common nosocomial pathogens in medical centers in parts of Europe, Australia, Asia, Africa, South America and the USA. Despite their worldwide distribution, the prevalence of these organisms differs at national, state and municipal levels (1-6). Many factors affect the reported prevalence of MRSA, including the laboratory methods used to identify resistant strains, movement of colonized or infected patients or personnel between institutions, patient populations at risk within a given hospital, infection control practices, and probably antibiotic utilization patterns. A number of these issues are discussed in a special series of articles that appear in this issue of the European Journal.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
